In recent trading session, Mainz Biomed N.V (NASDAQ:MYNZ) saw 0.55 million shares changing hands at last check today with its beta currently measuring 0.31. Company’s recent per share price level of $4.71 trading at -$0.18 or -3.68% at last check today assigns it a market valuation of $10.46M. That most recent trading price of MYNZ’s stock is at a discount of -859.66% from its 52-week high price of $45.20 and is indicating a premium of 22.51% from its 52-week low price of $3.65. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.15 million shares which gives us an average trading volume of 213.95K if we extend that period to 3-months.
Mainz Biomed N.V (NASDAQ:MYNZ) trade information
Upright in the red during last session for losing -3.68%, in the last five days MYNZ remained trading in the red while hitting it’s week-highest on Friday, 03/07/25 when the stock touched $4.71 price level, adding 16.19% to its value on the day. Mainz Biomed N.V’s shares saw a change of 9.03% in year-to-date performance and have moved -13.58% in past 5-day. Mainz Biomed N.V (NASDAQ:MYNZ) showed a performance of -40.30% in past 30-days. Number of shares sold short was 79743.0 shares which calculate 0.23 days to cover the short interests.
Mainz Biomed N.V (MYNZ) estimates and forecasts
This year revenue growth is estimated to rise 18.54% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 250k for the same. And 1 analysts are in estimates of company making revenue of 300k in the next quarter. Company posted 181.67k and 214.76k of sales in current and next quarters respectively a year earlier. In 2025, company’s earnings growth rate is likely to be around 83.27% while estimates for its earnings growth in next 5 years are of 69.27%.
Mainz Biomed N.V (NASDAQ:MYNZ)’s Major holders
Insiders are in possession of 4.98% of company’s total shares while institution are holding 11.05 percent of that, with stock having share float percentage of 11.63%. Investors also watch the number of corporate investors in a company very closely, which is 11.05% institutions for Mainz Biomed N.V that are currently holding shares of the company. NORTHERN TRUST CORP is the top institutional holder at MYNZ for having 29934.0 shares of worth $12004.0. And as of 2024-06-30, it was holding 0.1414 of the company’s outstanding shares.
The second largest institutional holder is VONTOBEL HOLDING LTD., which was holding about 25000.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.1181 of outstanding shares, having a total worth of $10025.0.
